Droplet Digital PCR in immuno-oncology: Advancing quality control, biomarker discovery, and liquid biopsy monitoring
Explore the versatile role of ddPCR technology in immuno-oncology for precise and sensitive nucleic acid quantification
Explore the versatile role of ddPCR technology in immuno-oncology for precise and sensitive nucleic acid quantification
Join us for thought-provoking conversations with leading scientists as we reflect on the remarkable achievements of science and explore the possibilities ahead
Learn about remarkable advances in sepsis diagnosis and monitoring over the past 25 years as we highlight some of the most notable breakthroughs.
Watch exclusive video interviews with industry experts on advances in biomarker discovery, breakthroughs in cancer diagnostics, and more
Discover the game-changing advancements and key discussions driving lab automation forward
Goal of the project is to provide a device to every warfighter in the field where access to diagnostic testing or medical personnel is limited
Prof. Umberto Malapelle, Chair of Predictive Molecular Pathology Laboratory and Scientific Secretary of the International Society of Liquid Biopsy shares insights on how predictive molecular pathology could improve targeted therapies and personalized care
Discover the latest tools and techniques to expand your research capacity with expert-led presentations on spectroscopy, proteomics sample preparation, efficient, cost-effective, and value-based healthcare, and more
Fujirebio adds another two markers to its fully automated blood-based biomarker portfolio
The new biomarker tests will allow further study of the clinical utility of NfL in diverse disease conditions
Discover the latest tools and techniques to expand your research capacity with expert-led presentations on RNA therapies, immunotherapies, antibody-drug conjugates, and more
The new partnership will aim to advance the development of antigen-targeted EVOC probes for early cancer detection
Strategic partnership aims to accelerate biomarker development to improve the diagnosis of Alzheimer’s disease and and other neurological disorders
How can a proteomics platform that can measure over 7,000 protein biomarkers from one sample be used to assess an individual’s overall health, monitor disease progression, and inform healthcare decisions?
SelectScience speaks with drug discovery experts to learn how they are using protein biomarkers across different stages of the drug development process
Discover the latest tools and techniques to expand your research in life science with expert-led presentations on automated proteomic sample prep, biomarker research, immunofluorescence, and much more
Cast your vote for the product that has had the biggest impact on your drug discovery & development research to be in with a chance of winning a $500 Amazon Gift Card (or equivalent currency)
Watch this on demand webinar to help produce cost- and time- effective bioanalytical strategies
The head of bioinformatics at Sengenics reveals more about the emerging field of bioinformatics, and how the knowledge gained can be applied to enhance immunoprofiling to find meaningful biomarker signatures